CO5170446A1 - Estuche de ensayo para el diagnostico de encefalopaatias espongiformes transmisibles - Google Patents

Estuche de ensayo para el diagnostico de encefalopaatias espongiformes transmisibles

Info

Publication number
CO5170446A1
CO5170446A1 CO00029093A CO00029093A CO5170446A1 CO 5170446 A1 CO5170446 A1 CO 5170446A1 CO 00029093 A CO00029093 A CO 00029093A CO 00029093 A CO00029093 A CO 00029093A CO 5170446 A1 CO5170446 A1 CO 5170446A1
Authority
CO
Colombia
Prior art keywords
transmissible spongiform
diagnosis
test case
spongiform encephalopathy
spongiform encephalopathies
Prior art date
Application number
CO00029093A
Other languages
English (en)
Inventor
Mark Stephen Rogers
Matthias Giese
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of CO5170446A1 publication Critical patent/CO5170446A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G01N2333/57—IFN-gamma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Estuche de ensayo para diagnóstico con el fin de detectar encefalopatías espongiformes transmisibles, caracterizado porque contiene todos los elementos necesarios para la detección de la expresión modificada de una proteína marcadora para encefalopatías espongiformes transmisibles, en donde estos elementos son útiles para al menos una de las siguientes etapasa) tomar una muestra de sangre de un mamífero vivo,b) concentrar células objetivo desde esta muestra de sangre,c) determinar la expresión de una proteína marcadora para encefalopatías espongiformes transmisibles en las células objetivo,d) comparar el valor obtenido con el valor de control.
CO00029093A 1999-04-21 2000-04-19 Estuche de ensayo para el diagnostico de encefalopaatias espongiformes transmisibles CO5170446A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19918141A DE19918141A1 (de) 1999-04-21 1999-04-21 Verfahren zur Diagnose von übertragbaren Spongiformen Enzephalopathien

Publications (1)

Publication Number Publication Date
CO5170446A1 true CO5170446A1 (es) 2002-06-27

Family

ID=7905394

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00029093A CO5170446A1 (es) 1999-04-21 2000-04-19 Estuche de ensayo para el diagnostico de encefalopaatias espongiformes transmisibles

Country Status (26)

Country Link
US (2) US20030064424A1 (es)
EP (1) EP1093585A1 (es)
JP (1) JP2002543389A (es)
KR (1) KR20020021774A (es)
CN (1) CN1347501A (es)
AR (1) AR023553A1 (es)
AU (1) AU4297400A (es)
BG (1) BG106021A (es)
BR (1) BR0009843A (es)
CA (1) CA2367696A1 (es)
CO (1) CO5170446A1 (es)
CZ (1) CZ20013771A3 (es)
DE (1) DE19918141A1 (es)
EA (1) EA200101021A1 (es)
EE (1) EE200100547A (es)
HK (1) HK1043188A1 (es)
HU (1) HUP0200777A2 (es)
ID (1) ID30392A (es)
IL (1) IL145253A0 (es)
MX (1) MXPA01010546A (es)
NO (1) NO20015094L (es)
PL (1) PL350985A1 (es)
SK (1) SK15032001A3 (es)
TR (1) TR200103011T2 (es)
UY (1) UY26109A1 (es)
WO (1) WO2000065357A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0026604D0 (en) 2000-10-31 2000-12-13 Roslin Inst Edinburgh Diagnostic method
DE10108099A1 (de) * 2001-02-19 2002-09-12 Cenas Ag Verfahren zum Nachweis spezifischer Proteine und Verwendung
WO2002074986A2 (en) * 2001-03-21 2002-09-26 Exonhit Therapeutics S.A. An early pre-symptomatic prion diagnostic blood test for encephalopathies
WO2002079511A1 (en) * 2001-03-30 2002-10-10 Chronix Biomedical, Inc. Diagnostic detection of nucleic acids
GB0110172D0 (en) * 2001-04-25 2001-06-20 Pa Consulting Services Improved analytical test approach for blood
AU2002344245A1 (en) * 2001-05-29 2002-12-09 Reinhold Kiehl Method for determining peptides or proteins, mass spectrometry for metals and determination of conductivity capacity
JP4093736B2 (ja) 2001-06-28 2008-06-04 株式会社日立メディコ 核磁気共鳴診断装置および診断システム
GB2379737A (en) * 2001-09-05 2003-03-19 Univ Geneve Diagnostic method for spongiform encephalopathy disease
KR20020033126A (ko) * 2002-03-08 2002-05-04 김용선 병원성 프리온 단백의 n말단의 비효소적 당화반응 최종산물의 검출에 의한 프리온 질환의 진단
WO2004050908A1 (en) * 2002-12-03 2004-06-17 Exonhit Therapeutics S.A. An early pre-symptomatic prion diagnostic blood test for encephalopathies
RU2251699C1 (ru) * 2003-09-25 2005-05-10 Киселев Всеволод Иванович Способ ранней и доклинической диагностики цервикального рака
ES2246113B1 (es) * 2003-10-31 2007-04-01 Consejo Sup. De Invest. Cientificas Procedimiento de deteccion ante-mortem de proteinas prionicas por espectroscopia infrarroja y su uso en el diagnostico de encefalopatias espongiformes transmisibles.
US7368243B2 (en) * 2004-07-09 2008-05-06 Chronix Biomedical Detection of nucleic acids to assess risk for bovine spongiform encephalopathy
US7309589B2 (en) * 2004-08-20 2007-12-18 Vironix Llc Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing
EP1749892B1 (en) * 2005-08-02 2008-03-19 Roche Diagnostics GmbH Nucleotide sequence for assessing TSE
US7798645B2 (en) 2006-05-16 2010-09-21 Mark Costin Roser Visual and memory stimulating retina self-monitoring system

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789655A (en) * 1994-05-13 1998-08-04 The Regents Of The University Of California Transgenic animals expressing artificial epitope-tagged proteins
US6008435A (en) * 1994-05-13 1999-12-28 The Regents Of The University Of California Detecting cow, sheep and human prions in a sample and transgenic mice used for same
JP3495738B2 (ja) * 1995-09-14 2004-02-09 ザ レジェンツ オブ ザ ユニバーシティー オブ カリフォルニア 天然ＰｒＰｓｃ特異的抗体
DK0891552T4 (da) * 1996-04-03 2009-05-04 Stichting Dienst Landbouwkundi Fremgangsmåde til detektion af prionsygdomme
US5834593A (en) * 1996-11-05 1998-11-10 The Regents Of The University Of California Soluble form of PrPSC which is insoluble in native form
DE19648599C1 (de) * 1996-11-23 1998-02-19 Tavira Holdings Ltd Wirkdruckgeber eines Durchflußmessers
EP0861900A1 (en) * 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions
US6221614B1 (en) * 1997-02-21 2001-04-24 The Regents Of The University Of California Removal of prions from blood, plasma and other liquids
US5891641A (en) * 1997-02-21 1999-04-06 The Regents Of The University Of California Assay for disease related conformation of a protein
DE69837539T2 (de) 1997-05-30 2008-01-03 Weiss, Stefan, PD Dr. Löslicher Lamininrezeptor Vorläufer und Verfahren zur Verhinderung von Laminininteraktionen
US6165784A (en) * 1997-10-14 2000-12-26 The United States Of America As Represented By The Secretary Of Agriculture Antibodies for the detection of prion protein as an indication of transmissible spongiform encephalopathies
US5977324A (en) * 1998-02-20 1999-11-02 The Regents Of The University Of California Process for concentrating protein with disease-related conformation
US6528269B1 (en) * 1998-06-22 2003-03-04 Case Western Reserve University Immunological agents specific for prion protein (PRP)
US6166187A (en) * 1999-03-05 2000-12-26 The Regents Of The University Of California Method of concentrating prion proteins in blood samples
GB0119339D0 (en) * 2001-08-08 2001-10-03 Medical Res Council Method

Also Published As

Publication number Publication date
KR20020021774A (ko) 2002-03-22
DE19918141A1 (de) 2000-10-26
JP2002543389A (ja) 2002-12-17
US20030129667A1 (en) 2003-07-10
BG106021A (en) 2002-06-28
AU4297400A (en) 2000-11-10
HUP0200777A2 (en) 2002-06-29
NO20015094D0 (no) 2001-10-19
UY26109A1 (es) 2000-12-29
NO20015094L (no) 2001-12-17
EP1093585A1 (en) 2001-04-25
MXPA01010546A (es) 2002-06-04
PL350985A1 (en) 2003-02-24
IL145253A0 (en) 2002-06-30
HK1043188A1 (zh) 2002-09-06
CZ20013771A3 (cs) 2002-03-13
WO2000065357A1 (en) 2000-11-02
SK15032001A3 (sk) 2002-02-05
EE200100547A (et) 2003-02-17
EA200101021A1 (ru) 2002-04-25
AR023553A1 (es) 2002-09-04
BR0009843A (pt) 2002-02-13
US20030064424A1 (en) 2003-04-03
TR200103011T2 (tr) 2002-02-21
ID30392A (id) 2001-11-29
CA2367696A1 (en) 2000-11-02
CN1347501A (zh) 2002-05-01

Similar Documents

Publication Publication Date Title
CO5170446A1 (es) Estuche de ensayo para el diagnostico de encefalopaatias espongiformes transmisibles
Saito et al. An alternative mitophagy pathway mediated by Rab9 protects the heart against ischemia
Chen et al. The Munc13 proteins differentially regulate readily releasable pool dynamics and calcium-dependent recovery at a central synapse
Xu et al. Epigallocatechin gallate (EGCG) inhibits alpha-synuclein aggregation: A potential agent for Parkinson’s disease
Risser et al. Excitatory amino acids and monoamines in parahippocampal gyrus and frontal cortical pole of adults with Down syndrome
WO2006062895A3 (en) Systems and methods for in-vivo optical imaging and measurement
WO2008093746A1 (ja) 蛍光観察装置および蛍光観察方法
Toral-Ojeda et al. Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle
Rao et al. Proteomic analysis of fibroblastema formation in regenerating hind limbs of Xenopus laevis froglets and comparison to axolotl
BRPI0516120A (pt) método de identificação de ovos vivos, aparelho de ovoscopia que identifica ovos vivos e método de diagnóstico da saúde de um embrião dentre uma pluralidade de ovos, e, método de identificação do sexo de uma pluralidade de ovos
Hyde et al. Spatiotemporal properties of high-speed calcium oscillations in the pedunculopontine nucleus
Ch'Ng et al. Cell biological mechanisms of activity-dependent synapse to nucleus translocation of CRTC1 in neurons
Rödel et al. Blood flow suppresses vascular anomalies in a zebrafish model of cerebral cavernous malformations
Baumann et al. Denervation-induced activation of the ubiquitin-proteasome system reduces skeletal muscle quantity not quality
Cully et al. Nox4–RyR1–Nox2: Regulators of micro-domain signaling in skeletal muscle
Kwon et al. Nonmuscle myosin II localization is regulated by JNK during Drosophila larval wound healing
Tagliavini et al. Ultrastructural changes in muscle cells of patients with collagen VI-related myopathies
Jia et al. Dynamic recruitment of CDK5RAP2 to centrosomes requires its association with dynein
AR035956A1 (es) Deteccion y cuantificacion de isoformas de prion en enfermedades neurodegenerativas mediante espectrometria de masas.
Dona et al. NINL and DZANK1 co-function in vesicle transport and are essential for photoreceptor development in zebrafish
Kravić et al. Ubiquitin profiling of lysophagy identifies actin stabilizer CNN2 as a target of VCP/p97 and uncovers a link to HSPB1
Costa et al. Transportin 3 (TNPO3) and related proteins in limb girdle muscular dystrophy D2 muscle biopsies: A morphological study and pathogenetic hypothesis
Virtanen et al. Development of inhibitory synaptic inputs on layer 2/3 pyramidal neurons in the rat medial prefrontal cortex
Yako et al. Mitochondria dynamics in the aged mice eye and the role in the RPE phagocytosis
AR107440A1 (es) ANTICUERPOS MONOCLONALES ESPECÍFICOS PARA EL ANTÍGENO pIII DE ADENOVIRUS HUMANO (ADV), PRODUCIDOS Y SECRETADOS POR HIBRIDOMAS CELULARES, ÚTILES PARA LA DETECCIÓN Y EL DIAGNÓSTICO DE LA INFECCIÓN CAUSADA POR ADV

Legal Events

Date Code Title Description
FA Application withdrawn